Cargando…
Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis
Oleoylethanolamide (OEA) is a naturally occurring bioactive lipid belonging to the family of N-acylethanolamides. A variety of beneficial effects have been attributed to OEA, although the greater interest is due to its potential role in the treatment of obesity, fatty liver, and eating-related disor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910994/ https://www.ncbi.nlm.nih.gov/pubmed/33513874 http://dx.doi.org/10.3390/nu13020394 |
_version_ | 1783656242602835968 |
---|---|
author | Romano, Adele Friuli, Marzia Del Coco, Laura Longo, Serena Vergara, Daniele Del Boccio, Piero Valentinuzzi, Silvia Cicalini, Ilaria Fanizzi, Francesco P. Gaetani, Silvana Giudetti, Anna M. |
author_facet | Romano, Adele Friuli, Marzia Del Coco, Laura Longo, Serena Vergara, Daniele Del Boccio, Piero Valentinuzzi, Silvia Cicalini, Ilaria Fanizzi, Francesco P. Gaetani, Silvana Giudetti, Anna M. |
author_sort | Romano, Adele |
collection | PubMed |
description | Oleoylethanolamide (OEA) is a naturally occurring bioactive lipid belonging to the family of N-acylethanolamides. A variety of beneficial effects have been attributed to OEA, although the greater interest is due to its potential role in the treatment of obesity, fatty liver, and eating-related disorders. To better clarify the mechanism of the antiadipogenic effect of OEA in the liver, using a lipidomic study performed by (1)H-NMR, LC-MS/MS and thin-layer chromatography analyses we evaluated the whole lipid composition of rat liver, following a two-week daily treatment of OEA (10 mg kg(−1) i.p.). We found that OEA induced a significant reduction in hepatic triacylglycerol (TAG) content and significant changes in sphingolipid composition and ceramidase activity. We associated the antiadipogenic effect of OEA to decreased activity and expression of key enzymes involved in fatty acid and TAG syntheses, such as acetyl-CoA carboxylase, fatty acid synthase, diacylglycerol acyltransferase, and stearoyl-CoA desaturase 1. Moreover, we found that both SREBP-1 and PPARγ protein expression were significantly reduced in the liver of OEA-treated rats. Our findings add significant and important insights into the molecular mechanism of OEA on hepatic adipogenesis, and suggest a possible link between the OEA-induced changes in sphingolipid metabolism and suppression of hepatic TAG level. |
format | Online Article Text |
id | pubmed-7910994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79109942021-02-28 Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis Romano, Adele Friuli, Marzia Del Coco, Laura Longo, Serena Vergara, Daniele Del Boccio, Piero Valentinuzzi, Silvia Cicalini, Ilaria Fanizzi, Francesco P. Gaetani, Silvana Giudetti, Anna M. Nutrients Article Oleoylethanolamide (OEA) is a naturally occurring bioactive lipid belonging to the family of N-acylethanolamides. A variety of beneficial effects have been attributed to OEA, although the greater interest is due to its potential role in the treatment of obesity, fatty liver, and eating-related disorders. To better clarify the mechanism of the antiadipogenic effect of OEA in the liver, using a lipidomic study performed by (1)H-NMR, LC-MS/MS and thin-layer chromatography analyses we evaluated the whole lipid composition of rat liver, following a two-week daily treatment of OEA (10 mg kg(−1) i.p.). We found that OEA induced a significant reduction in hepatic triacylglycerol (TAG) content and significant changes in sphingolipid composition and ceramidase activity. We associated the antiadipogenic effect of OEA to decreased activity and expression of key enzymes involved in fatty acid and TAG syntheses, such as acetyl-CoA carboxylase, fatty acid synthase, diacylglycerol acyltransferase, and stearoyl-CoA desaturase 1. Moreover, we found that both SREBP-1 and PPARγ protein expression were significantly reduced in the liver of OEA-treated rats. Our findings add significant and important insights into the molecular mechanism of OEA on hepatic adipogenesis, and suggest a possible link between the OEA-induced changes in sphingolipid metabolism and suppression of hepatic TAG level. MDPI 2021-01-27 /pmc/articles/PMC7910994/ /pubmed/33513874 http://dx.doi.org/10.3390/nu13020394 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Romano, Adele Friuli, Marzia Del Coco, Laura Longo, Serena Vergara, Daniele Del Boccio, Piero Valentinuzzi, Silvia Cicalini, Ilaria Fanizzi, Francesco P. Gaetani, Silvana Giudetti, Anna M. Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis |
title | Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis |
title_full | Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis |
title_fullStr | Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis |
title_full_unstemmed | Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis |
title_short | Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis |
title_sort | chronic oleoylethanolamide treatment decreases hepatic triacylglycerol level in rat liver by a pparγ/srebp-mediated suppression of fatty acid and triacylglycerol synthesis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910994/ https://www.ncbi.nlm.nih.gov/pubmed/33513874 http://dx.doi.org/10.3390/nu13020394 |
work_keys_str_mv | AT romanoadele chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT friulimarzia chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT delcocolaura chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT longoserena chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT vergaradaniele chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT delbocciopiero chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT valentinuzzisilvia chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT cicaliniilaria chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT fanizzifrancescop chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT gaetanisilvana chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis AT giudettiannam chronicoleoylethanolamidetreatmentdecreaseshepatictriacylglycerollevelinratliverbyappargsrebpmediatedsuppressionoffattyacidandtriacylglycerolsynthesis |